What MindWalk Holdings Corp. does.

MindWalk Holdings Corp. is presently traded on the Nasdaq Capital Market with the ticker symbol “HYFT”. The Board of Directors of the Company (the “Board”) previously approved a change in our corporate name from ImmunoPrecise Antibodies Ltd. to MindWalk Holdings Corp., which became effective on September 3, 2025. The Company began trading under a new symbol on the Nasdaq, “HYFT”, effective September 4, 2025. The executive headquarters of the Company are situated at Industrious 823 Congress Ave, Suite 300, Austin, Texas 78701. The registered and records office of the Company is located at 1600 – 925 West Georgia Street, Vancouver, British Columbia V6C 3L2, Canada.

MindWalk Holdings Corp. is a Bio-Native AI company that applies artificial intelligence proprietary biological pattern analysis and wet-lab capabilities to support therapeutic discovery. The Company develops BioIntelligence infrastructure that life sciences AI, and increasingly agentic AI, requires, which is designed to integrate AI, data, and full-stack wet lab capabilities into one connected discovery ecosystem. At its core is HYFT® Technology, the Company’s patented, function-aware representation of biology, refined over 20 years of curation into a biological representation of 660 million patterns and 25 billion relationships spanning sequence and structural biology.

Revenue and profit, by fiscal year.

More on HYFT.

• MindWalk Holdings Corp. summary
• MindWalk Holdings Corp. financial statements
• MindWalk Holdings Corp. key metrics
• MindWalk Holdings Corp. health scores and style box
• MindWalk Holdings Corp. earnings
• MindWalk Holdings Corp. dividends
• MindWalk Holdings Corp. valuation
• MindWalk Holdings Corp. ownership and insiders
• MindWalk Holdings Corp. peers

Figures from MindWalk Holdings Corp.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.